Search Results for: BIOTHERAPEUTICS DEVELOPMENT The Role of
Articles
BIOTHERAPEUTICS DEVELOPMENT - The Role of Flow Electroporation in Vaccine Development May 4, 2015
James Brady, PhD, Karen Donato, PhD, and Krista Steger, PhD, indicate that with unmatched quality, flexibility, and scalability, flow electroporation is a universal, cost-effective platform that supports the full range of biotherapeutic and vaccine development activities.
DRUG DELIVERY - EUDRACAP® Select - Examining a Case From Development to Clinical Trial February 29, 2024
Lucas Paulo Cusin, Kamlesh Oza, PhD, and Steven Smith, et al focus on the development of a customized functional coated capsule for the delivery of live biotherapeutics and demonstrate its effectiveness in the oral delivery of a sensitive proprietary microbiome ecosystem while simplifying the drug development process.
DRUG DEVELOPMENT EXECUTIVE - Thermo Fisher Scientific: What to Expect From the Next Wave of RNA-Based Therapeutics February 29, 2024
Dr. Dale Patterson, Vice President and General Manager, Molecular Biology at Thermo Fisher Scientific, delves into the world of RNA therapies and understand their next act beyond COVID-19.
Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics January 28, 2021
Pacira BioSciences, Inc. recently announced that the company will lead an equity investment in GeneQuine Biotherapeutics GmbH…..
Alethia Biotherapeutics Announces Receipt of FDA Authorization to Begin Phase 2 Development May 26, 2020
Alethia Biotherapeutics recently announced the US FDA has cleared its Phase 2 Investigational new drug (IND) application for AB-16B5, a...Adaptate Biotherapeutics Formed to Develop Antibody-Based Therapies That Modulate Gamma Delta T-Cells October 17, 2019
GammaDelta Therapeutics, a company focussed on harnessing the unique properties of gamma delta T-cells to develop transformational immunotherapies, recently announced...BIOSIMILAR DEVELOPMENT - Approval of Biosimilar Medicines Through Totality of the Evidence June 4, 2019
Hillel Cohen, PhD, outlines the evolution of biosimilar approvals and describes the process of analytical and clinical testing followed in the development of a biosimilar, with use of data from the scientific literature.
NapaJen Pharma & Astellas Pharma Establish Research Collaboration for Discovery & Development of Novel Oligonucleotides March 20, 2019
NapaJen Pharma, Inc. recently announced it has entered into a research collaboration with Astellas Pharma Inc. for the discovery and...SPECIAL FEATURE - Platform Technologies - Derisking & Transforming Drug Development September 29, 2017
Contributor Cindy H. Dubin, in this second annual report, speaks with several exciting and innovative companies whose platform technologies are transforming drug development.
DRUG DEVELOPMENT - To De-Risk Patient Acceptance of Biologic Drugs, Focus Early on Delivery September 11, 2017
Jeannie Joughin, PhD, asks what does a pharmaceutical company do when everyone wants more effective new therapies but no one – including third-party payers – wants to pay the price for their development? De-risk the drug development process, in every possible way.
REMD Biotherapeutics Announces Dosing of First Type 1 Diabetes Patient With Glucagon Receptor Monoclonal Antibody April 12, 2016
REMD Biotherapeutics, Inc., together with its subsidiary, Beijing CoSci-REMD Bio Med-Tech Co, Ltd (CoSci-REMD Bio), recently announced that the first...Albumedix & Eleven Biotherapeutics Announce Albumin Variant Technology Agreement February 8, 2016
Eleven Biotherapeutics, Inc. and Albumedix recently announced they have entered into an agreement that will see Albumedix acquire Eleven’s proprietary...Janus Biotherapeutics Enters Collaboration With Roche August 25, 2015
Janus Biotherapeutics recently announced it has entered into a collaboration with Roche for the development of a small molecule toll-like...Eleven Biotherapeutics Announces Top-Line Results From Pivotal Phase III Study May 20, 2015
Eleven Biotherapeutics, Inc. recently announced top-line results from the OASIS study, the company’s first pivotal Phase III study of its...FUJIFILM Completes Acquisition of Biotherapeutics Company December 18, 2014
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, recently announced the completion of its acquisition of Kalon Biotherapeutics LLC,...SPECIAL REPORT - Outsourcing Formulation Development and Manufacturing: An Early Approach Saves Time and Money March 31, 2013
In this Special Report, Contributor Cindy H. Dubin asks many of the leading companies in this sector what challenges pharma currently faces in formulation and manufacturing and how they, as third-party providers, are helping to alleviate those burdens.
ENGINEERING BIOLOGY - Scaling Engineering Biology to Accelerate Advances in Healthcare February 28, 2024
Raquel Sanches-Kuiper and Matthew Hayes, PhD, say the development of a benchtop synthesis platform has the potential to expedite the discovery and development time for drugs and biotherapeutics, greatly accelerating the rate at which engineering biology can shape the future of healthcare.
Clinigen Divests Global Rights to Four Cancer Support Therapies to CNX Therapeutics August 10, 2023
Clinigen Limited has completed the divestment of four cancer supportive care products from its established brands portfolio to CNX Therapeutics, a speciality pharmaceutical company with a focus on….
EXTRACELLULAR VESICLES - Engineering Extracellular Vesicles to Create Next-Generation Therapeutics October 3, 2022
David Lowe, PhD, Justin Hean, PhD, Dave Carter, PhD, and Antonin de Fougerolles, PhD, say EVs exhibit key properties that make them extremely attractive as therapeutics, particularly their safety profile and potential for low immunogenicity. In order to effectively unlock this potential, some key challenges remain, such as the development of EV product manufacture and characterization methodologies and rapid pharmacokinetics.
NJIT Researchers Unlock a New Method for Testing Protein-Based Drugs September 28, 2022
New Jersey Institute of Technology researchers have unveiled a new lab technique they say represents a “paradigm shift” in how...
